Maintenance Rituximab After R-CHOP Shows Continued Benefit in Older Patients With MCL
Induction therapy with R-CHOP followed by maintenance rituximab continued to show improvements in survival and responses compared with R-CHOP and interferon-alpha maintenance in older patients with mantle cell lymphoma.